Dr. Karin Hehenberger is a Type 1 diabetic and the founder of Lyfebulb, an educational and social platform dedicated to helping those with chronic illnesses lead better lives. Prior to founding Lyfebulb, Dr. Hehenberger held executive positions in the life sciences and devoted her career to identifying, analyzing, developing and promoting products across the therapeutics, devices and consumer healthcare industries.